Promising drug cocktail targets tough sarcomas in young patients
NCT ID NCT02945800
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a combination of two chemotherapy drugs, nab-paclitaxel and gemcitabine, in 59 teenagers and young adults whose sarcoma (a type of bone or soft tissue cancer) had returned or not responded to standard treatment. The main goals were to see if the drug combo could shrink tumors or stop them from growing, and to check how safe and tolerable the treatment was. Participants received the drugs in cycles, and their tumors were measured with scans every two cycles.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.I. duPont Hospital for Children, Delaware - Nemours
Wilmington, Delaware, 19603, United States
-
Carolinas Medical Center, Levine Cancer Institute
Charlotte, North Carolina, 28303, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Connecticut Children's Medical Center
Hartford, Connecticut, 06103, United States
-
H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center
Tampa, Florida, 33612, United States
-
Holtz Children's Hospital at the University of Miami
Miami, Florida, 33136, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
-
Shand's Hospital for Children at the University of Florida
Gainesville, Florida, 32608, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231, United States
-
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, 35294, United States
-
University of Kentucky
Lexington, Kentucky, 40506, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can engineered immune cells tackle childhood sarcoma?
- Can AI read tumor slides to outsmart childhood cancer?
- Could a massive tissue bank unlock sarcoma's secrets?
- Ultrasound, CT, and MRI put to the test for identifying childhood neck lumps